These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 30029166)

  • 1. Made from concentrate? A national web survey assessing dab use in the United States.
    Sagar KA; Lambros AM; Dahlgren MK; Smith RT; Gruber SA
    Drug Alcohol Depend; 2018 Sep; 190():133-142. PubMed ID: 30029166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new method of cannabis ingestion: the dangers of dabs?
    Loflin M; Earleywine M
    Addict Behav; 2014 Oct; 39(10):1430-3. PubMed ID: 24930049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Naturalistic Administration of Cannabis Flower and Concentrates With Intoxication and Impairment.
    Bidwell LC; Ellingson JM; Karoly HC; YorkWilliams SL; Hitchcock LN; Tracy BL; Klawitter J; Sempio C; Bryan AD; Hutchison KE
    JAMA Psychiatry; 2020 Aug; 77(8):787-796. PubMed ID: 32520316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cannabis Involvement and Demand in Frequent Concentrate Users Versus Predominantly Flower Users.
    Skrzynski CJ; Napolitan A; Hitchcock L; Minhas M; MacKillop J; Bryan AD; Bidwell LC
    J Stud Alcohol Drugs; 2023 Mar; 84(2):214-221. PubMed ID: 36971716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. To Dab or Not to Dab: Rising Concerns Regarding the Toxicity of Cannabis Concentrates.
    Alzghari SK; Fung V; Rickner SS; Chacko L; Fleming SW
    Cureus; 2017 Sep; 9(9):e1676. PubMed ID: 29152433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adult use of highly-potent Δ9-THC cannabis concentrate products by U.S. state cannabis legalization status, 2021.
    Hasin DS; Borodovsky J; Shmulewitz D; Walsh C; Struble CA; Livne O; Habib MI; Fink DS; Aharonovich E; Budney A
    Addict Behav; 2023 May; 140():107617. PubMed ID: 36736229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Higher average potency across the United States is associated with progression to first cannabis use disorder symptom.
    Arterberry BJ; Treloar Padovano H; Foster KT; Zucker RA; Hicks BM
    Drug Alcohol Depend; 2019 Feb; 195():186-192. PubMed ID: 30573162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A little "dab" will do ya' in: a case report of neuro-and cardiotoxicity following use of cannabis concentrates.
    Rickner SS; Cao D; Kleinschmidt K; Fleming S
    Clin Toxicol (Phila); 2017 Nov; 55(9):1011-1013. PubMed ID: 28644052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. "Time for dabs": Analyzing Twitter data on marijuana concentrates across the U.S.
    Daniulaityte R; Nahhas RW; Wijeratne S; Carlson RG; Lamy FR; Martins SS; Boyer EW; Smith GA; Sheth A
    Drug Alcohol Depend; 2015 Oct; 155():307-11. PubMed ID: 26338481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Understanding dabs: contamination concerns of cannabis concentrates and cannabinoid transfer during the act of dabbing.
    Raber JC; Elzinga S; Kaplan C
    J Toxicol Sci; 2015 Dec; 40(6):797-803. PubMed ID: 26558460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cannabis Concentrate Use in Adolescents.
    Meier MH; Docherty M; Leischow SJ; Grimm KJ; Pardini D
    Pediatrics; 2019 Sep; 144(3):. PubMed ID: 31451609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploring cannabis concentrates on the legal market: User profiles, product strength, and health-related outcomes.
    Cinnamon Bidwell L; YorkWilliams SL; Mueller RL; Bryan AD; Hutchison KE
    Addict Behav Rep; 2018 Dec; 8():102-106. PubMed ID: 30167450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Examining Associations Between Cannabis Use Disorder and Measures of Weekly and Within-Day Cannabis Frequency, Quantity, and Potency in College Students.
    Piercey CJ; Mataczynski M; Stallsmith VT; Emery NN; Karoly HC
    Cannabis Cannabinoid Res; 2024 Jun; 9(3):e917-e923. PubMed ID: 37699241
    [No Abstract]   [Full Text] [Related]  

  • 14. Associations between butane hash oil use and cannabis-related problems.
    Meier MH
    Drug Alcohol Depend; 2017 Oct; 179():25-31. PubMed ID: 28750253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A within-person comparison of the subjective effects of higher vs. lower-potency cannabis.
    Okey SA; Meier MH
    Drug Alcohol Depend; 2020 Nov; 216():108225. PubMed ID: 32858319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impacts of potency, warning messages, and price on preferences for Cannabis flower products.
    Shi Y; Cao Y; Shang C; Pacula RL
    Int J Drug Policy; 2019 Dec; 74():1-10. PubMed ID: 31382201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Twitter-based survey on marijuana concentrate use.
    Daniulaityte R; Zatreh MY; Lamy FR; Nahhas RW; Martins SS; Sheth A; Carlson RG
    Drug Alcohol Depend; 2018 Jun; 187():155-159. PubMed ID: 29669296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. User characteristics and effect profile of Butane Hash Oil: An extremely high-potency cannabis concentrate.
    Chan GCK; Hall W; Freeman TP; Ferris J; Kelly AB; Winstock A
    Drug Alcohol Depend; 2017 Sep; 178():32-38. PubMed ID: 28624604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterizing marijuana concentrate users: A web-based survey.
    Daniulaityte R; Lamy FR; Barratt M; Nahhas RW; Martins SS; Boyer EW; Sheth A; Carlson RG
    Drug Alcohol Depend; 2017 Sep; 178():399-407. PubMed ID: 28704769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tracking Dabbing Using Search Query Surveillance: A Case Study in the United States.
    Zhang Z; Zheng X; Zeng DD; Leischow SJ
    J Med Internet Res; 2016 Sep; 18(9):e252. PubMed ID: 27637361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.